Request Sample Inquiry
Newborn Screening Market

Newborn Screening Market

Newborn Screening Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

143

Base Year:

2021

Date

Jul - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1705

Segments Covered
  • By Product Consumables, Instruments, Hearing Screening Instruments, Pulse Oximeters
  • By Test Dry Blood Spot Tests, Hearing Screening Test, CCHD Screening Test
  • By Technology Immune Assays & Enzymatic Assays, Tandem Mass Spectrometry, Molecular Assays, Hearing Screening Technologies, Pulse Oximetry, Other Technologies
  • By End User Clinical Laboratories, Hospitals
  • By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Forecast YearsForecast Years: 2022 - 2028
Historical YearsHistorical Years: 2016 - 2021
Revenue 2021Revenue 2021: USD 729.5 Million
Revenue 2028Revenue 2028: USD 1164 Million
Revenue CAGRRevenue CAGR (2022 - 2028): 8.1%
Fastest Growing Region Fastest Growing Region (2022 - 2028) Asia Pacific
Largest Region Largest Region (2021): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics
  • Region Level Market Share
  • Import Export Analysis
  • Production Analysis
  • Others Request Customization Speak To Analyst
Newborn Screening Market Share

Market Synopsis:

The Global Newborn Screening Market was valued USD 729.5 Million in the year 2021 and is anticipated to reach a value of USD 1164 Million by the year 2028. The Global Market is forecasted to grow to exhibit a Compound Annual Growth Rate (CAGR) of 8.1% over the forecast period.

Newborn Screening Market Size, 2021 To 2028 (USD Million)

Newborn Screening is a public health program run by various hospitals in which newborn babies are screened and identified with rare but serious medical conditions (genetic, hormonal, or metabolic conditions) that can interfere with average growth but are easy to treat. Newborn Screening includes a variety of tests, such as hearing tests, urine tests, and dry blood tests, that are performed during the first few hours or days of an infant's life. These tests have the potential to help prevent a variety of health problems and deaths. From a simple urine and blood screening test to a more complex and comprehensive screening system capable of detecting many different conditions, Newborn Screening has developed. Newborn Screening tests detect various markers in an infant's blood that can increase or decrease if the infant has certain diseases.

Congenital Hypothyroidism, Phenylketonuria (PKU), Cystic Fibrosis (CF), and other metabolic conditions can now be diagnosed using newborn screening tests that affect fat metabolism or protein metabolism. Additionally, the increased incidence of heart disease and genetic disorders among newborns is expected to fuel the Global Newborn Screening Market. Furthermore, governmental and private organizations' initiatives and advancements in new technologies are propelling the Global Newborn Screening Market forward. However, on the other hand, insufficient facts among parents about neonatal screening, a shortage of skilled professionals, and inaccuracy in some tests are significant factors that may impede the growth of the Global Newborn Screening Market.

Market Segmentation:

The Newborn Screening Market is segmented based on Product, Test, Technology, End User, and Region. Based on the segment Product, the market is further sub-segmented as Consumables Instruments, Hearing Screening Instruments, and Pulse Oximeters. Furthermore, based on the segment Tests, the market is sub-segmented into Dry Blood Spot Tests, Hearing Screening Tests, and CCHD Screening Tests. On the other hand, based on Technology, the market is sub-segmented as Immune Assays & Enzymatic Assays, Tandem Mass Spectrometry, Molecular Assays, Hearing Screening Technologies, Pulse Oximetry, and Other Technologies. Finally, the End-User segment is further categorized into sub-categories as Clinical Laboratories and Hospitals.

Based on Test:

Based on the segment Test, the Dried Blood Spot Tests (DBS) sub-segment is expected to maintain its dominance in the forecasted period. DBS sampling has been used for many years to screen newborn babies for congenital metabolic diseases. The benefits of DBS sampling include low volume requirements, Ease of occupying via finger or heel stick with minimal training, and Ease of transport and sample stability. In addition, this test can detect autism, lymphomas, leukemia, and other metabolic disorders. The advantage of Dried Blood Spot analysis is that it collects a small sample volume that can be easily moved. As a result, rising diseases in newborns are driving the market growth.

North America is projected to grow at the fastest CAGR during the forecast period

North America currently dominates the Newborn Screening Market and is expected to do so in the future. This is primarily due to the growing incidences of genetic diseases and mandatory testing in all 50 states of the U.S. The United States has observed the most extensive market growth in North America. This is primarily due to the growing incidence of newborn disorders and the increased demand for advanced systems. Every newborn in the United States is screened post-birth, with the analysis of diagnostic markers in blood spots collected on filter paper on the second day of an infant's life. However, Newborn Screening programs are run state-by-state in the United States due to a lack of consistency among testing panels in many states. However, with the growing incidence of genetic disorders and the increasing number of childbirths, Asia Pacific is expected to experience significant growth in the Global Newborn Screening Market. The evolving healthcare infrastructure, technological advancements, and increasing awareness about Newborn Screening are expected to drive the Newborn Screening Market growth in Latin America, the Middle East, and Africa during the forecast period.

Competitive Landscape:

The key players in the Global Newborn Screening Market include- PerkinElmer (US), Demant A/S (Denmark), Natus Medical (US), Bio-Rad Laboratories (US), Danaher Corporation (US), Medtronic (Ireland), Chromsystems Instruments & Chemicals GmbH (Germany), Trivitron Healthcare (India), Baebies (US), Recipe Chemicals+Instruments (Germany), and others.

Segmentation of the Global Newborn Screening Market:

Parameter Details
Segments Covered
  • Product (Consumables, Instruments, Hearing Screening Instruments, Pulse Oximeters)
  • Test (Dry Blood Spot Tests, Hearing Screening Test, CCHD Screening Test)
  • Technology (Immune Assays & Enzymatic Assays, Tandem Mass Spectrometry, Molecular Assays, Hearing Screening Technologies, Pulse Oximetry, Other Technologies)
  • End User (Clinical Laboratories, Hospitals)
  • Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • PerkinElmer (US)
  • Demant A/S (Denmark)
  • Natus Medical (US)
  • Bio-Rad Laboratories (US)
  • Danaher Corporation (US)
  • Medtronic (Ireland)
  • Chromsystems Instruments & Chemicals GmbH (Germany)
  • Trivitron Healthcare (India)
  • Baebies (US)
  • Recipe Chemicals+Instruments (Germany)
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

Newborn Screening Market to Reach Valuation of USD 1164 Million by 2028 – Growing Prevalence of Newborn Disorders Drives the Market
In terms of revenue, the Global Newborn Screening Market is expected to reach USD 1164 Million by 2028, growing at a Compound Annual Growth Rate (CAGR) of 8.1% from 2022 to 2028. The growing prevalence of newborn disorders, rising government support for Newborn Screening Market, and advancements i...
FAQ
Frequently Asked Question
  • The global Newborn Screening valued at USD 729.5 Million in 2020 and is expected to reach USD 1164 Million in 2028 growing at a CAGR of 8.1%.

  • The prominent players in the market are PerkinElmer (US), Demant A/S (Denmark), Natus Medical (US), Bio-Rad Laboratories (US), Danaher Corporation (US), Medtronic (Ireland), Chromsystems Instruments & Chemicals GmbH (Germany), Trivitron Healthcare (India), Baebies (US), Recipe Chemicals+Instruments (Germany).

  • The market is project to grow at a CAGR of 8.1% between 2021 and 2028.

  • The driving factors of the Newborn Screening include

    • Rising prevalence of newborn disorders

  • North America was the leading regional segment of the Newborn Screening in 2020.